BANGKOK, June 2 (TNA) – The World Health Organization on June 1 approved the emergency use of the COVID-19 vaccine developed by Sinovac of China, the Chinese embassy in Thailand said.

WHO approved the use of CoronaVac developed by Sinovac Biotech, a Chinese pharmaceutical company.

WHO announced on June 1 that it advised people aged 18 years and over be inoculated with two jabs of the vaccine against COVID-19 and both doses be 2-4 weeks apart.

Full story: tna.mcot.net

TNA